This page summarizes information about the clinical trials that support investigation of both approved and experimental medicines. This information includes information about the interventions and their sponsoring organizations. Note that these data are derived from ClinicalTrials.gov, with information corrected and disambiguated to convey more accurate detail about these trials. Phase 4 trials are currently excluded on this page by default, as this data will be analyzed separately at a later date.
Trials with Experimental APIs
Top 5 (by most trials)
autologous hematopoietic stem cells (607) allogeneic adipose derived mesenchymal stem cell (318) umbilical cord mesenchymal stem cells (309) cd19 car-t cells (277) autologous mesenchymal stem cells (253)Trials with Approved APIs
Top 5 (by most trials)
human fecal microbiota (399) allogeneic hematopoietic stem cells (389) ciltacabtagene autoleucel (56) axicabtagene ciloleucel (31) autologous culture chondrocytes (29)Trials with Unapproved APIs
Top 5 (by most trials)
red blood cells (77) platelets (47)Phase 1 Sponsors
Top 5 (by most trials)
National Cancer Institute (NCI) (354) People's Liberation Army of China (211) University of Texas at Houston (135) University of Washington (113) Baylor University (113)Phase 2 Sponsors
Top 5 (by most trials)
National Cancer Institute (NCI) (482) People's Liberation Army of China (160) University of Texas at Houston (143) University of Washington (135) University of Minnesota (92)